Approaches to oocyte meiotic arrest in vitro and impact on oocyte developmental competence

• Published in: Biology of reproduction Vol. 106; no. 2; pp. 243 - 252
• Main Authors: Richani, Dulama, Gilchrist, Robert B
• Format: Journal Article
• Language: English
• Published: United States Society for the Study of Reproduction 22.02.2022; Oxford University Press
• Subjects: Animals; Cell interactions; Cumulus Cells - metabolism; Cyclic AMP; Cyclic GMP; Cyclic nucleotides; Female; in vitro maturation; In Vitro Oocyte Maturation Techniques - veterinary; IVM; Meiosis; Nucleotides; oocyte; oocyte meiotic arrest; OOCYTE SPECIAL ISSUE; Oocytes; Oocytes - metabolism; Oogenesis; Ovarian Follicle; Ovulation; Protein biosynthesis; Protein synthesis; Reproductive technology; IVM; in vitro maturation; oocyte; oocyte meiotic arrest
• ISSN: 0006-3363; 1529-7268
• DOI: 10.1093/biolre/ioab176

Oocytes are maintained in a state of meiotic arrest following the first meiotic division until ovulation is triggered. Within the antral follicle, meiotic arrest is actively suppressed in a process facilitated by the cyclic nucleotides cGMP and cAMP. If removed from this inhibitory follicular environment and cultured in vitro, mammalian oocytes undergo spontaneous meiotic resumption in the absence of the usual stimulatory follicular stimuli, leading to asynchronicity with oocyte cytoplasmic maturation and lower developmental competence. For more than 50 years, pharmacological agents have been used to attenuate oocyte germinal vesicle (GV) breakdown in vitro. Agents that increase intra-oocyte cAMP or prevent its degradation have been predominantly used; however, agents such as kinase and protein synthesis inhibitors have also been trialed. Twenty years of research demonstrates that maintaining GV arrest for a period before in vitro maturation (IVM) improves oocyte developmental competence, and is likely attributed to maintenance of bidirectional communication with cumulus cells leading to improved oocyte metabolic function. However, outcomes are influenced by various factors including the mode of action of the modulators, dose, treatment duration, species, and the degree of hormonal priming of the oocyte donor. Cyclic GMP and/or cAMP modulation in a prematuration step (called pre-IVM) prior to IVM has shown the greatest consistency in improving oocyte developmental competence, whereas kinase and protein synthesis inhibitors have proven less effective at improving IVM outcomes. Such pre-IVM approaches have shown potential to alter current use of artificial reproductive technologies in medical and veterinary practice.